Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer ...

TD Cowen维持对GlaxoSmithKline (GSK:LN) (NYSE: GSK)的"持有"评级，目标价保持在1,790.00英镑不变。该公司的立场是在GlaxoSmithKline报告其哮喘药物depemokimab的III期试验结果积极之后做出的，这与关键意见领袖（KOL）预期的约50%哮喘发作减少率一致。这一表现与已获批准的IL-5抑制剂相似。

2023年全球和中国疫苗市场规模分别达3013.4亿元（人民币）和935.66亿元，结合历史趋势和发展环境等方面因素，预计到2029年全球疫苗市场规模预计将达4540.77亿元。 竞争层面，报告也包含了各企业主要经营数据、市场表现，以及全球行业CR3、CR10。全球疫苗行业核心企业包括Astellas Pharma Inc, AstraZeneca, Emergent BioSolutions, ...

In a report released today, Peter Welford from Jefferies maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

德国图宾根和美国波士顿 - GlaxoSmithKline (GSK) 报告了其基于 mRNA 的季节性流感疫苗的令人鼓舞的 Phase 2 结果,该疫苗使用了生物制药公司 CureVac N.V. (NASDAQ:CVAC) 的技术。这项研究达到了所有预定的终点,展示了对甲型和乙型流感毒株的积极免疫反应,以及可接受的安全性和反应原性特征。 这款疫苗候选品基于 CureVac 专有的第二代 mRN ...

TD Cowen maintained a Hold rating on GlaxoSmithKline (NYSE:GSK:LN) (NYSE: GSK), with a consistent price target of $1,790.00. The firm's stance comes after GlaxoSmithKline reported positive Phase ...

GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...

1 Day BIOC 2.49% DJIA -0.25% Russell 2K 0.04% Health Care/Life Sciences -1.42% ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.